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Abstract
We present selected highlights from research that appeared during 2015 on
Tourette syndrome and other tic disorders. Topics include phenomenology,
comorbidities, developmental course, genetics, animal models, neuroimaging,
electrophysiology, pharmacology, and treatment. We briefly summarize articles
whose results we believe may lead to new treatments, additional research or
modifications in current models of TS.
 This article is included in the channel.Tics 
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Introduction
This article is the second in the TS Research Highlights series1. 
These articles are meant to disseminate recent scientific progress 
on Gilles de la Tourette Syndrome (TS). During each year, the arti-
cle will be a work in progress, maintained as a web page on the 
Authorea online authoring platform (the working draft for 2016 
appears here). After the calendar year ends, the article is final-
ized and submitted as the annual update for the Tics channel on 
F1000Research2.
Methods
We searched PubMed on 22 Jan 2016 using the search strategy: 
(“Tic Disorders”[MeSH] OR Tourette NOT Tourette[AU]) AND 
2015[PDAT]. This search returned 202 citations and includes arti-
cles appearing online in 2015 but not officially published by year 
end (from journals that still focus on the paper user interface). We 
also reviewed F1000Prime recommendations and presentations 
of interest at selected medical conferences. Articles were chosen 
based on a purely subjective assessment of interest, guided by our 
judgment of possible future impact on the field.
Results
Phenomenology and natural history
Tic suppression. Since tic suppression is part of the treatment 
protocol for the Comprehensive Behavioral Intervention for Tics 
(CBIT) and for Exposure and Response Prevention, there has been 
increased interest in investigating the characteristics of tic sup-
pression and the factors that affect it. A study of 26 TS adolescents 
compared free ticcing with a tic suppression condition3. During 
the free ticcing condition, tic distribution across body locations 
was consistent with the view that most tics occur at the level of 
the shoulders and above: eye tics were the most frequent, followed 
by facial/cervical tics, and those involving the arms and legs. Tics 
involving the trunk were the least common. During the tic suppres-
sion condition, eye tics increased in 10 subjects, as did hand tics 
in 3 subjects. Tic suppression was most successful for tics in body 
locations generally associated with fewer tics, such as the legs and 
trunk. The authors suggest that tic suppression involves specific, 
rather than global, inhibition since some types of tics were easier 
to suppress than others. Historically, other categories have been 
used to classify tics, such as simple vs. complex tics and motor vs. 
phonic tics. The results of this study suggest that future research 
may benefit from including body location in tic analyses.
By definition, children with Tourette syndrome (TS) have had tics 
for over a year. They can often suppress their tics briefly and they 
do so more effectively when rewarded for successful suppression. 
It has not been known whether the ability to suppress tics develops 
only with practice over the years of having tics or whether the ability 
to suppress tics is present when tics initially occur. Greene and col-
leagues addressed this question in children whose tics had developed 
within the past few months4. When children received tokens with 
monetary value for tic-free intervals, they had significantly more 
of these intervals compared to a baseline, unrewarded condition. 
This result suggests the possibility that behavior therapy for tics may 
work, at least for some children, even before TS can be diagnosed.
Another study examined the association between tic suppression 
and quality of life. Although most tic patients frequently try to 
suppress tics, they find suppressing them uncomfortable and dis-
tracting. However, those patients who are more satisfied with their 
ability to suppress their tics also report a higher quality of life5.
Sensory phenomena. Premonitory urges are common in TS, are 
perceived as triggers for tics, and are as bothersome as the tics 
themselves to many people with TS. Premonitory urges have a 
sensory component and many TS patients also report sensory 
sensitivities. Researchers have been clarifying the nature of 
premonitory urges and attempting to determine the underlying 
causes of sensory sensitivities.
Scores on the Premonitory Urge for Tics Scale (PUTS) and the 
University of São Paulo Sensory Phenomena Scale (USP-SPS) 
were significantly correlated with total tic severity, tic complex-
ity and vocal tic scores in youth and adults with TS6. The PUTS 
and USP-SPS scores were also correlated with scores on the 
Dimensional Yale-Brown Obsessive-Compulsive Scale. This 
study provides additional evidence that the association between 
premonitory urges and tics is complex and may be influenced by 
obsessive-compulsive tendencies.
Another study examined the association between premonitory 
urges and interoceptive awareness7. Interoceptive awareness was 
measured by how well subjects were able to mentally track their 
heartbeats, without being able to take their own pulse, during a 
specific period of time. Interoceptive awareness, tic severity, and 
obsessive-compulsive symptom severity were used in a multiple 
regression to predict PUTS scores. Greater interoceptive aware-
ness and tic severity were significantly associated with higher 
PUTS scores while OCD symptom severity was not. The authors 
suggest that high interoceptive awareness may lead people to set 
a low threshold for perception of their own internal physiological 
sensations and therefore cause them to interpret these sensations 
as an urge to tic. Interestingly, TS subjects had lower interoceptive 
awareness than controls overall, suggesting that this downregula-
tion of interoception might reflect a compensatory process.
Symptoms and comorbidity. Recent research has again 
demonstrated the wide prevalence of TS-associated comorbidities 
and is a reminder of the need to perform studies with large enough 
sample sizes to examine the effects of comorbidities on the 
dependent variables of interest.
A retrospective review of 1,000,000 people in the Taiwan National 
Health Insurance Research Database examined the association 
between epilepsy and TS8. 1,062 children and adolescents with 
TS were matched on age and sex with a control group of 3,186 
subjects. The TS group had an 18-fold increased risk of epilepsy 
compared to the control group; the risk was still elevated 16-fold 
after adjusting for comorbidities (i.e., bipolar disorder, depression, 
learning difficulties, autism, anxiety disorders, sleep disorders). 
The authors acknowledge the possibility that some tics may have 
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been mistaken for seizures, given the nature of the data set, but these 
data do suggest an important hypothesis for future confirmation.
In a large study of psychiatric comorbidity in TS, approximately 
800 families were recruited primarily from TS specialty clinics in 
four different countries over a 16-year period9. A total of 1374 par-
ticipants with TS and 1142 family members unaffected by TS were 
included. 86% of the TS participants had at least one psychiatric 
comorbidity and 72% had either OCD or ADHD. Mood, anxiety 
and disruptive behavior disorders each occurred in approximately 
30% of the TS participants. The genetic correlations between TS 
and mood were accounted for by ADHD and OCD, while ADHD 
alone accounted for the genetic correlations of TS with anxiety and 
disruptive behavior disorders.
A study of 400 patients seen at a TS specialty clinic found that 
39% had coprolalia and 20% had copropraxia10. When the 222 
patients with full comorbidity data were examined, only 13.5% 
had “pure” TS (i.e., without comorbidities). None of the “pure” 
TS group had coprolalia and none had a family history of 
obsessive-compulsive disorder.
Emotional regulation difficulties were described in three studies, 
reminding us that for many TS patients, tics are not their most prob-
lematic symptoms. Greater irritability was seen in TS adults with 
more severe tics and those with comorbid ADHD11. Eddy et al. 
found that both male and female TS subjects, compared to controls, 
reported more distress during emotionally intense situations and 
rated their abilities to take other people’s perspectives lower12. An 
experienced clinician who has done research on “rage attacks” in 
TS has provided a clinically useful summary of current knowledge 
regarding aggressive symptoms in TS, OCD, ADHD and mood 
disorders, and described treatment options13. Given that emotional 
regulation difficulties are frequently associated with greater tic 
severity, improving emotional modulation skills may be an appro-
priate target of psychological interventions.
More research is also being conducted on personality differences 
associated with TS. A small study of 17 male adolescents14 found 
that the only significant difference between the TS subjects and 51 
age- and gender-matched controls on the Minnesota Multiphasic 
Personality Inventory-Adolescent version was that the TS subjects 
scored higher on the Obsessiveness Content Scale. In contrast, a 
study of 50 TS adults in Germany used a variety of instruments to 
measure psychological symptoms and personality traits15. Comor-
bidities were common (41% OCD, 28% depression, 26% ADHD). 
Patients with OCD had more severe tics and there was a trend for 
those with ADHD to have more severe tics. Only 29% of the patients 
had no pathological personality traits, as measured by the Inventory 
of Clinical Personality Accentuations. The demand-anxious trait 
was the most common personality trait seen in patients and was 
present in 39%, while histrionic personality traits were not found 
in any patients. Personality traits in patients with “pure” TS were 
comparable to those of the control group. Interestingly, ADHD did 
not contribute to increased probability of pathological personal-
ity traits. Although quality of life was affected by both personality 
traits and comorbidities, personality traits had a larger impact on 
quality of life.
Course. More research is being conducted on the developmental 
progression of tics and other symptoms in TS. This work may 
provide clues that help clarify what factors contribute to the 
appearance and disappearance of transient tics and what factors 
explain the disappearance or amelioration of tics as children with 
TS enter adulthood.
One study examined home videos recorded in the first 6 months 
of life from 34 children who were exhibiting autistic behaviors in 
their second year of life16. Families reported that development dur-
ing the first year of life had been normal. Videos of 18 boys were 
examined in detail. The primary focus of the study was on autism, 
though 11 of the 18 subjects were later diagnosed with TS. The 
nearly ubiquitous availability of home baby videos in some cultures 
suggests that a similar pseudo-prospective study design could be 
used to identify behavioral features predicting later development 
of TS.
The clinical characteristics of children who developed TS before 
the age of 4 were compared with those whose tics developed at 
age 6 or older17. The younger group had a higher rate of speech 
dysfluencies (e.g., stuttering) and oppositional defiant disorder. 
There was no difference between the two groups in prevalence 
of ADHD or obsessive-compulsive symptoms. Interestingly, the 
children in the early-onset group were more likely to have moth-
ers with tics. The authors attributed this to mothers with tics being 
more likely to recognize tics in their children. The authors also 
suggest that prenatal or perinatal maternal environmental fac-
tors may contribute to the development of tics. An alternative 
explanation may relate to the fact that TS is much less common in 
girls than in boys. Consequently, tics in a woman may represent 
a higher genetic load, resulting in a more severe form of tics and 
an earlier age of onset in her children.
Researchers re-evaluated 75 patients previously seen at a 
university-based TS clinic after a mean follow-up of 9 years18. 
Reported TS impairment was more likely to decrease over time in 
males and increase in females. In adulthood, women were more 
likely than men to have an expansion of the number of body regions 
exhibiting tics, primarily in the upper extremities. This result suggests 
that sex continues to influence TS symptoms beyond adolescence.
Etiology
Genetics. The most important genetics news of the year may have 
been the presentation by Huang and colleagues at the Tourette 
World Congress in London in June, 2015, reporting on a large 
collaborative study of copy number variants (CNVs) in approxi-
mately 2,500 TS cases and 3,500 controls19. They first tested some 
CNVs previously reported in various neurological and psychi-
atric illnesses; the most significant confirmation in this sample 
was of exonic deletions in NRXN1, a gene previously implicated 
in autism and TS20. They also searched for new, large CNVs and 
identified a novel TS locus, CNTN6, that was significant at a 
whole-genome level by permutation testing. This gene and 4 of 
the 32 next most likely candidates this analysis identified are neu-
ral adhesion molecules20. CNTN6 is a reasonable candidate for 
etiologically contributing to TS: its expression in the brain varies 
during development21, knockout mice show motor deficits22, and an 
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independent study found a variety of neurological and psychiat-
ric symptoms (including 2 with OCD) in 14 patients identified by 
CNTN6 CNVs23. On the other hand, fewer than 1% of TS cases in 
this sample had CNVs in CNTN6, so its overall importance in TS 
remains to be more fully characterized.
A large collaborative group24 studied AADAC, the gene encoding 
arylacetamide deacetylase, in which microdeletions had been identi-
fied in a previous, smaller copy number variation study. The authors 
provide evidence from several sources supporting the connection 
of AADAC and TS, including a significant overall association, 
new patients with AADAC deletions, and evidence that AADAC 
is expressed in the brain, though most strongly in cerebellum, 
hippocampus and olfactory bulb, rather than the basal ganglia.
A collaborative genetic study25 demonstrated an association of 
TS with 33 genes related to glycolysis or glutamine metabolism. 
None of the individual genes would have survived correction for 
multiple testing and the results were consistent with a combined 
effect of many genetic variants of small effect. These results sug-
gest a new direction for future genetic, electrophysiological, imag-
ing and pharmacological studies.
Yu et al. reported a genome-wide association study (GWAS) from 
1,310 people with OCD, 834 with Tourette syndrome, 579 with both 
OCD and a chronic tic disorder, and over 5,500 controls matched 
for ancestry26. A significant polygenic component was identified for 
OCD without tics, but not for the combined patient group or other 
subgroups. Overall, this study is consistent with previous work but 
it provided disappointingly few novel results.
An international study examined tic symptoms in the United 
States and the Netherlands27. Three factors (complex vocal tics and 
obscene behavior, body tics, and head/neck tics) accounted for 49% 
of the variance in tic-related symptoms. There was no evidence 
of heritability for the second factor, but the h2r was approximately 
0.2 for the first and third factors when age and sex were included 
as covariates. Heritability for these narrower tic phenotypes is con-
siderably lower than the heritability estimates (up to 0.65) when 
comorbid conditions such as OCD and ADHD are included. These 
authors conclude that broader tic phenotypes, rather than narrower 
pure tic phenotypes, may be more successful at identifying the 
genetic mechanisms underlying TS.
Environmental risk factors. Researchers used data from the Avon 
Longitudinal Study of Parents and Children to identify maternal 
factors that increase the risk of tic disorders in offspring28. The Avon 
Longitudinal Study is an ongoing, prospective, pre-birth cohort 
study of all children born in Avon, United Kingdom, between April 
1, 1991, and December 31, 1992. Maternal questionnaires were 
administered throughout pregnancy and mothers also completed 
questionnaires about themselves and their children’s development 
every 6 months from the child’s birth to the age of 7 and then yearly 
thereafter. In the final multivariate model, chronic maternal anxiety, 
evident both before and after the child’s birth, was associated with 
TS or chronic tic disorder in children. This association may reflect 
shared genetic susceptibility or prenatal exposure.
Pathophysiology
Pathological studies. An important study follows up on the autopsy 
results from the Vaccarino lab by comparing RNA transcripts from 
the basal ganglia of 9 TS and 9 matched control subjects29. The 
most strongly associated set of downregulated transcripts involved 
striatal interneurons, consistent with the autopsy studies. The 
leading set of upregulated transcripts involved immune-related 
genes even though none of the TS subjects met proposed diagnostic 
criteria for PANDAS or PANS. The results obtained in the present 
study using brain tissue did not overlap with those of previous 
studies using blood samples. The authors interpret their results as 
implicating disrupted basal ganglia interneuron signaling in the 
pathophysiology of severe TS.
Animal models. Rodent and monkey tic models have been 
developed in order to study tic generation mechanisms more directly 
and a number of studies using rodent models were published 
in 2015. Removing about half of the cholinergic interneurons 
in the dorsolateral striatum produced increased fragmented 
grooming behavior in response to repeated unpredictable acoustic 
startle stimuli in mice and also increased repetitive sniffing 
in response to D-amphetamine challenge30. Ablation in the 
dorsomedial striatum did not produce similar deficits. None 
of the experimental conditions produced a change in prepulse 
inhibition. These results provide partial support for the autopsy 
data linking some characteristic TS symptoms to cholinergic 
interneuron deficits in the dorsolateral striatum.
A rat model was used to determine to what extent cortical and 
striatal input affected the temporal and spatial properties of motor 
tics31. Focal blockade of GABA-A receptors with bicuculline injec-
tions into the anterior striatal motor region produced focal tic-like 
movements of the forelimbs. Medium spiny neurons (MSNs) and 
fast spiking interneurons (FSIs) exhibited increased activity dur-
ing these movements, and all of the MSNs were only active during 
them. All of the FSIs were active during tics, but a minority fol-
lowed this increase in activity by a decrease. Four different patterns 
were seen in globus pallidus (GP) neurons. About half of the GP 
neurons demonstrated increased activity during the tic-like move-
ments, while the rest showed only inhibition or a combination of 
inhibition and excitation. The effects of cortical input were stud-
ied using short bursts of high-frequency electrical pulses applied 
at random intervals to the region of primary motor cortex repre-
senting the forelimb. Stimulation was provided before and after 
the bicuculline injections. The results suggested that the precise 
timing of tic occurrence was related to both incoming excitatory 
cortical input and the delay since the previous tic. These results 
support the fundamental involvement of the corticostriatal network 
with tic occurrence.
The role of GABA in tic generation was also studied in adult 
mice by injecting the GABA-A antagonist picrotoxin into areas 
throughout the cortex and striatum32. Infusions into the central and 
dorsolateral striatum produced tic-like movements of the front 
paw, hind paw or head. Infusions into the dorsomedial striatum did 
not have a significant behavioral effect. Infusion into the ventral 
striatum produced increased locomotor activation in addition to 
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sterotypical sniffing and wall licking without other tic-like move-
ments. Infusions into the sensorimotor cortex produced tic-like 
movements in addition to increased behavioral activation involv-
ing cage exploration, sniffing, and occasional licking. When an 
NMDA receptor antagonist was infused into the dorsolateral stria-
tum prior to infusing picrotoxin into the same location, tic frequency 
decreased significantly, thus demonstrating a role of glutamater-
gic activity in tic generation. Infusion of a GABA-A agonist into 
the sensorimotor cortex prior to picrotoxin infusion in the dor-
solateral striatum also resulted in significant tic suppression. 
EEG recordings ruled out seizure activity. The authors summarize 
these results as providing evidence that these tic-like movements 
require corticostriatal interactions, with a key role for glutatmateric 
afferents, rather than autonomous striatal activity.
In a genetically engineered mouse model of TS+OCD (“Ticcy” 
D1CT-7 transgenic mice)33, a small population of dopamine D1 
receptor-expressing (D1+) somatosensory cortical and limbic 
neurons is chronically potentiated, resulting in cortical and amy-
gdalar glutamatergic excitation of striatothalamic, striatopallidal 
and nigrostriatal subcircuits. Tics were decreased by the use of 
drugs that acted at different points in this “hyperglutamergic cor-
tico/amygdalo-striato-thalamo-cortical [CSTC] circuit”. Excita-
tory forebrain serotonin and norepinephrine activity was blocked 
by ritanserin (a serotonin 2a/2c antagonist) and prazosin (an 
α1 adrenergic antagonist) respectively. In contrast, downstream 
striatothalamic neurons’ glutamate-triggered GABA output and 
downstream nigrostriatal neurons’ glutamate-triggered co-modula-
tory dopamine output were blocked by moxonidine (an agmatine/ 
imidazoline-1 agonist) and bromocriptine (a D2 dopamine ago-
nist) respectively. All four of these drugs decreased tic frequency 
and were considered to be “circuit-breakers” for the hypergluta-
matergic CSTC circuit, thus supporting an important role of 
glutamate in generating the abnormal tic-like movements seen in 
these mice.
Neuroimaging studies. The challenges of using neuroimaging 
techniques to study pediatric and clinical subjects are described 
in detail along with suggestions concerning various strategies that 
can be used to collect higher quality data34. The profound effects 
of even very small head movements on structural MRI analyses 
were identified in a well-designed study35. T1-weighted MRI of 
brain was acquired in 12 healthy adults while they were still or 
engaged in specific types of movement including nodding, head 
shaking or a movement each subject invented and then repeated 
during the scan run. Even during scans when subjects attempted 
to remain still, there was an average of 3 mm/min of accumulated 
motion measured as root mean square displacement per minute. 
During the motion conditions, substantial impact was found on 
gray matter volume and thickness estimates. Apparent volume 
loss averaged approximately 0.7% mm/min of subject motion. 
The greatest reductions in gray matter occurred in pre- and post-
central cortex and in the temporal lobes. Motion-associated increases 
in thickness were seen in some frontal regions and deep sulci such as 
the medial orbital frontal region. Significant effects due to motion 
were still present even after excluding scans that failed a rigorous 
quality control procedure. Recommendations included reducing 
head motion during scans as much as possible, controlling for motion 
in statistical analyses, and using correlational analyses to determine 
the associations between head motion and the predictors of 
interest. Tisdall and colleagues described a method to limit the 
effects of movement artifacts by using a motion tracking system 
to provide prospective motion correction during scanning36.
A whole-brain analysis of cortical gray matter found reduced gray 
matter (GM) thickness in the insula and sensorimotor cortex for 
29 TS children and young adults compared to a matched control 
group37. GM thickness in these areas correlated negatively with 
Premonitory Urge for Tics Scale scores.
Resting-state functional magnetic resonance imaging identified 
greater functional connectivity between the right dorsal anterior 
insula (dAI) and the bilateral supplementary motor area (SMA) 
in TS adults compared to controls38. Post-hoc analyses found 
significant correlations between PUTS scores and connectivity 
between right dAI and right SMA2 and between right dAI and left 
SMA1. These regions may be involved in the increased awareness 
of body sensations that tend to be associated with premonitory 
urges. The authors paid attention to head movement and removed 
high-movement frames. However, recent result suggest that the 
motion threshold of 0.4mm used in this analysis, and the choice 
not to regress global signal, may not adequately remove artifac-
tual correlations between brain regions due to residual small head 
movements during the scan39.
A review summarized TS task-based fMRI studies in TS includ-
ing studies of tic suppression, voluntary motor execution, voluntary 
motor inhibition, and tic severity40. Free ticcing conditions (four 
studies) most commonly activated the left cerebellum, right cin-
gulum, left middle frontal gyrus, the Rolandic operculum, right 
pallidum, right SMA and thalamus. In motor response inhibition 
studies, on No-Go trials TS subjects exhibited greater activation in 
the bilateral prefrontal cortex, thalamus and caudate. In contrast, 
on voluntary motor execution tasks greater activation in TS sub-
jects was seen in the left prefrontal cortex, right cingulum, and the 
anterior SMA. Tic severity ratings were correlated with greater 
activation of the right dorsal premotor cortex and the SMA. Ante-
rior cingulate cortex and SMA were involved across task types. 
The thalamus was involved in all types of studies except for self- 
produced movements. The authors also briefly summarize the many 
issues related to neuroimaging tasks, such as associated comorbidi-
ties, medication effects, the need for longitudinal studies, and the 
confounding effect of tics during scanning. Additional neuroimag-
ing studies of note are noted in Table 1.
Electrophysiology. Local field potentials associated with 
spontaneous tics were studied in 3 patients during DBS surgery46. 
In all 3 patients repetitive thalamo-cortical coherent activity was 
present from 800 to 1500 msec prior to tic-associated muscle 
contractions. The frequency range affected varied among the patients 
and there were also ongoing intermittent intra-thalamic coherences 
that were not synchronized to the tics. The authors speculated that 
specific DBS targets may not matter as much as whether the target 
is part of the striato-pallido-thalamo-cortical network. However, 
since these patients were older and had very severe and complex 
tics, the authors acknowledge that it is not yet clear to what extent 
these results generalize to the TS population as a whole. Additional 
studies are noted in Table 1.
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Pharmacological studies. GABA involvement was studied in 
23 TS children, aged 8–12, and 67 controls using a battery of 
vibrotactile tasks with a subset of the children (19 with TS, 25 
controls) also undergoing GABA-edited magnetic resonance 
spectroscopy (MRS)47. Lower GABA concentration in the right 
sensorimotor cortex correlated with greater motor tic severity 
(r = –0.55). There were no significant differences between groups 
on reaction time and baseline amplitude discrimination threshold. 
However, TS children showed impaired tactile adaptation. The 
authors suggest that MRS GABA and tactile measures might useful 
as biomarkers of treatment response.
Positron emission tomography (PET) was used to investigate 
striatal D2/D3 dopamine receptor availability in TS subjects and 
controls using a D2/D3 receptor antagonist ([11C]raclopride) and 
an agonist with preferential binding to D3Rs ([11C](+)PHNO)48. 
No differences were found in striatal regions when the TS sub-
jects were compared with the controls, and there were no signifi-
cant correlations between receptor availability and tic severity. 
The authors concluded that their results challenge the widely held 
view that striatal dopamine receptors have a fundamental role in TS 
pathophysiology, though they acknowledged that endogenous 
dopamine levels may have influenced the results since these radi-
otracers are displaceable by physiological synaptic concentrations 
of dopamine.
Two studies examined dopamine D1 and D2-like receptors in 
healthy adults, measuring D1R and D2R availability during stop-
signal and continuous performance tasks49. Stop-signal reaction 
time was negatively correlated with both D1R and D2R receptor 
availability in the the associative and sensory motor regions of the 
striatum. In contrast, neither D1R nor D2R receptor availability 
was associated with performance on the continuous performance 
task, suggesting that stop-signal and continuous performance tasks 
are associated with different neurochemical mechanisms related 
to motor response inhibition. In a study of healthy adults, learning 
from positive outcomes was positively correlated with D1R binding 
in the putamen and caudate while there was an inverted U-shaped 
relationship (r2 = 0.19) between learning from negative outcomes 
and D2R binding in the putamen50. A dietary manipulation that 
reduced dopamine precursor levels significantly improved learning 
from negative outcomes. These results were interpreted as provid-
ing evidence that dopamine acts as a reward prediction error signal 
rather than as a saliency signal.
A detailed review focuses on histaminergic modulation of striatal 
function and its possible role in TS51. The authors suggest that dur-
ing wakefulness and increased attention, histaminergic neurons 
will be more active with the result that the striatum will be more 
responsive to thalamostriatal input and feed-forward inhibition will 
dominate. Several lines of evidence related to the role of histamine 
in TS were discussed. A family linkage study identified a rare muta-
tion in the gene encoding histidine decarboxylase. HDC transgenic 
mice exhibit decreased pre-pulse inhibition of startle responses 
and an increase in a variety of amphetamine-induced stereotyp-
ies that were prevented by pretreatment with histamine infusion or 
use of haloperidol. Reduced histamine production was suggested 
to produce dopaminergic disregulation of the basal ganglia and 
symptoms similar to those seen in TS.
Clinical and neuropsychological studies. In an intriguing report 
from a group studying social cognition, TS subjects exhibited 
intact mentalizing when observing animated triangles demonstrat-
ing simple and complex interactions52. However, unlike controls, 
TS subjects also tended to attribute human-like intentions when two 
triangles were moving randomly. This tendency was not explained 
by clinical symptoms or by other constructs such as executive 
function or alexithymia.
Two studies examined the effects of comorbidities on social and 
cognitive skills. Social responsiveness and cognitive flexibility 
were examined in TS children and adolescents53. TS subjects 
were rated as having poorer social motivation and skills, using the 
Social Responsiveness Scale, compared to age-matched controls. 
TS subjects also took significantly longer to complete the Trail 
Making Tests which measure cognitive flexibility and visual motor 
Table 1. Additional neuroimaging and electrophysiology studies.
Reference Comment
Motor execution and motor 
imagery41
An exploratory study found increased cortical premotor and prefrontal neural activation for both 
imagined and performed movements in TS subjects compared to controls. Premotor activation 
during the motor imagery task was correlated with tic severity.
Structural MRI in pediatric 
TS42
A preliminary report of a multi-site study with over 200 subjects found TS children had greater gray 
matter volume in the posterior thalamus, hypothalamus and midbrain in addition to decreased 
white matter volume in orbital prefrontal and anterior cingulate cortex.
DTI and the corpus 
callosum43
Axial diffusivity (AD) was reduced in treatment-naive boys with “pure TS” compared to controls. 
AD was negatively correlated with tic severity, although this result was not significant after 
Bonferroni correction.
TS and Chronic Tic 
Disorder44
Both TS and chronic tic disorder groups exhibited similar increases in parietal and central event-
related potentials, adding to evidence that TS and CTD may be the same illness.
Event-related potentials45 Reduced P300 amplitudes in frontal regions were related to TS-associated comorbidities rather than 
to TS itself.
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integration. However, of the 31 TS subjects, 11 had OCD, 18 had 
ADHD and 8 had an anxiety disorder. Once these comorbidities 
were taken into account, group differences on the Trail Making 
Tests and the Social Responsiveness Scale were no longer sig-
nificant. These findings demonstrate the need for studies to have 
adequate sample sizes to provide sufficient power to disentangle 
effects related specifically to tics rather than to other symptoms. 
Another study was designed to separate effects attributable to 
OCD54. Sustained attention, using a continuous performance test, 
was examined in 48 children and adolescents who had OCD alone, 
tic disorders (TD) alone or both OCD and TD. A high rate of 
ADHD was seen in all groups (62% of the OCD+TD group, 27% 
in the TD alone group, and 20% in the OCD alone group). Anxi-
ety was also frequent (77% in the OCD+TD group compared to 
49% for the other two groups combined). The OCD+ TD group had 
more errors of omission and higher reaction time variability. These 
results of this study provide additional evidence that the OCD+TD 
phenotype is associated with more severe symptoms including 
attentional difficulties and symptoms of anxiety.
Two studies examined motor control. In a clever analysis of video 
recordings of the eyes55, spontaneous blink rate, which is related 
to dopamine levels, was higher in children with TS than in con-
trols both during task performance and during a rest period. In 
contrast, pupil diameter, which is related to norepinephrine levels, 
was correlated with anxiety in TS subjects although not in controls. 
Researchers also used a cognitive control task to measure ability to 
properly update current task information, ignore competing infor-
mation when selecting between response options, and retrieve and 
use relevant response contingencies. Accuracy on this cognitive 
control task accounted for half of tic severity variance. In an unre-
lated study, TS children without ADHD or OCD had significantly 
greater difficulty maintaining postural stability than did age- and 
gender-matched controls, especially when subjects had access only 
to accurate vestibular, rather than visual or somatosensory, cues56.
Somatosensory sensitivity was compared in adults with “pure” 
TS and controls by establishing thresholds for externally applied 
stimuli57. No differences were found between the two groups, sup-
porting the view that the sensory abnormalities seen in TS may be 
related to abnormal interoceptive awareness or abnormal central 
sensorimotor processing.
Three recent studies examined the effects of attention on tic fre-
quency and the results have implications for how treatment pro-
tocols could be modified to increase effectiveness. In one study, 
the role of attention on tic frequency was examined under several 
conditions58. Tic frequencies were lower for 12 TS subjects during 
a baseline condition when they were alone in a room compared to 
when they were alone in a room looking at themselves in a mirror. 
Researchers then determined whether the increase in frequency was 
due to increased attention to the tics themselves or due to increased 
self-awareness in general. In addition to the conditions previously 
described, 16 subjects were also shown videos of themselves while 
they were not ticcing. Tic frequency was again lower during the 
baseline compared to the mirror condition. Tic frequency was even 
lower when subjects were watching the video of themselves while 
not ticcing. The authors suggest that future treatments teach patients 
to attend to states when they experience fewer tics. Another study 
of TS adults59 compared tic frequency while subjects were engaged 
in tasks that involved attending to particular fingers, colored circles, 
or whether a tic had occurred during a specific 2-second interval. 
Observations for these tasks were made both during free ticcing 
and tic suppression. Not surprisingly, more tics were seen during a 
baseline free ticcing condition. During the attention tasks, tic fre-
quency was greatest while subjects focused on their tics. In con-
trast, tic frequency decreased during the color attention condition 
and decreased further during the finger attention condition. When 
subjects suppressed their tics, they reduced their baseline tic fre-
quency similarly across all attention conditions. These results are 
consistent with the idea that internally-directed attention, especially 
with a focus on tics, may contribute to momentary increases in tic 
severity. The authors suggested that behavioral treatment might be 
more effective if it focused on teaching patients to focus on external 
events and voluntary actions when they are in situations that are 
most likely to result in ticcing. Anecdotal evidence has suggested 
that tics decrease when people are involved in musical activity, so 
Bodeck et al. systematically studied the effects of music.60 Ques-
tionnaires completed by 29 patients supported the idea that listen-
ing to music and performing music decrease tic frequency. Eight 
TS subjects were then observed in a variety of conditions. Tics 
were almost completely eliminated when subjects were perform-
ing music. Listening to music and using mental imagery of musical 
performance also resulted in decreases in tic frequency. The authors 
suggested that focused attention, along with fine motor control and 
goal-directed behavior, produced the decrease in tics.
The stereotyped nature of tics has led some to suggest that the neu-
ral systems involved in habitual behavior may also be associated 
with tic generation. A complex, three-stage instrumental learning 
paradigm was used to compare medicated and unmedicated TS 
adults with a control group to determine whether they differed in 
goal-directed vs. habitual behavior61. During the first stage, subjects 
learned to associate six different stimuli with six specific outcome 
pictures and a specific response (i.e., left or right key press). During 
the second stage, subjects were presented with two outcomes with 
an indication that one outcome was devalued (i.e., no longer associ-
ated with point rewards) and subjects had to press the key associated 
with the outcome that would still generate points. During the third 
stage (i.e., “slip-of-action” stage), the six outcomes were presented 
simultaneously with indications that two outcomes were devalued 
so that responding to the associated stimuli would no longer gen-
erate points. Subjects were instructed to press the key associated 
with stimuli associated with the still valued outcomes (i.e., “Go”) 
and withhold the response (i.e., “No-Go”) for stimuli associated 
with devalued outcomes. This task determined whether excessive 
“slips of action” were related to outcome devaluation insensitiv-
ity. A control Go/No-Go task, which involved devaluation of cue-
ing stimuli, was used to measure to measure response rates where 
high rates on this task would indicate working memory deficits or 
deficient response inhibition. There were no group performance dif-
ferences for the first two stages of the instrumental learning task 
or on the baseline Go/No-Go task. However, unmedicated patients 
showed a significantly higher response rate to devalued outcomes 
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compared to controls (in Bonferroni-corrected post hoc analyses), 
while there was no difference between medicated subjects and 
controls. In addition, tic severity in unmedicated subjects was cor-
related with response rates to devalued outcomes and with stronger 
structural connectivity between the right supplementary motor 
cortex and the posterior putamen. The results obtained in this 
study contrasted with results on similar tasks obtained with sub-
jects with obsessive-compulsive disorder without tics. The 
authors argued that over-reliance on habits in OCD without tics is 
associated with impaired knowledge of response-outcome asso-
ciations, while this type of learning was intact in both TS groups 
in this study. They concluded that habit formation is enhanced 
in unmedicated TS subjects but medication may normalize 
responses.
Treatment
Psychotherapy. 2015 saw several practical advances in the 
psychotherapeutic treatments available for tics. TicHelper.com 
is a commercial adaptation of Comprehensive Behavioral Inter-
vention for Tics (CBIT) to the Internet, discussed at the London 
congress in 2015.62 It is potentially an important treatment 
option, especially for the many TS patients who do not live near a 
behavior therapist. Efficacy testing is ongoing (see the trial sum-
mary at ClinicalTrials.gov).
McGuire et al. dug into the data from 2 previously reported, 
pivotal, randomized controlled CBIT studies that together enrolled 
over 200 children and adults63. The superior treatment benefit 
from CBIT, compared to a control therapy, could be attributed to 
differential improvement in only a few types of tics, including throat 
clearing, sniffing, and complex tics. In general, vocal tics were 
more likely to improve following CBIT treatment. The controlled 
breathing used as a competing response for vocal tics may have 
allowed patients to direct attention away from the associated pre-
monitory urges in a way that muscle-tensing competing responses 
for motor tics did not. This report also extends previous information 
about premonitory phenomena, including varying prevalence of 
premonitory urges across specific tic types.
“Living with Tics” is a modularized cognitive-behavioral treat-
ment focused on decreasing tic-related impairment and improv-
ing quality of life. This treatment program was recently tested in a 
randomized, wait-list control study, with the active intervention 
including up to 10 weekly sessions for children and adolescents64. 
Treatment modules focused on a variety of themes including self-
esteem, emotion regulation, parent training, cognitive restructur-
ing, coping at school, overcoming tic-related avoidance, and 1 or 
2 sessions of habit-reversal training. Active treatment led to 
improved child-rated quality of life and reduced blinded clinician-
rated tic impairment compared to the wait-list control group. An 
additional 7 wait-listed youth then participated in the treatment 
program resulting in data on 19 participants for open-trial analyses. 
With the larger sample size the reductions in tic severity (i.e., 30%), 
anxiety, obsessive-compulsive symptoms, and parent-rated impair-
ment were significant. Both the youth and their parents reported 
satisfaction with the intervention, serving as a reminder that 
improving quality of life can be a desired treatment goal.
A small, uncontrolled open trial of mindfulness-based stress reduc-
tion treatment involved 18 individuals who were at least 16 years 
old.65 Treatment consisted of eight weekly two-hour group classes 
and one four-hour retreat. Participants were taught a tic-specific 
meditation exercise that involved noticing any urges to tic while 
maintaining a focus on one’s breathing rather than trying to change 
or eliminate the urge to tic. Only one subject dropped out and 
overall tic severity was decreased by 20% for participants who 
completed the program. An independent evaluator rated ten subjects 
as “much improved” or “very much improved” and these subjects 
were considered treatment responders. The gains for the fifteen 
participants who had not had medication changes in the interim 
were maintained at a one month follow-up visit.
An unblinded trial of psychotherapy using a cognitive psychophysi-
ological model of tic behavior was conducted with 102 adults who 
had TS or chronic tic disorder66. Ten weeks of individual psycho-
therapy involved a number of components including increasing tic 
awareness; improving muscle control; preventing excessive muscle 
tension; decreasing an overactive action style; identifying low and 
high risk activities in terms of tic probability; highlighting differ-
ences in behaviors, thoughts and feelings related to differences in 
tic probability; decreasing perfectionistic beliefs linked to tension; 
generalization; and relapse prevention. These psychotherapy com-
ponents were chosen because prior research suggested that some 
people with tics have perfectionist beliefs leading to an “impulsive 
overactive style” that produces frustration and tension in addition to 
tics. Large effect sizes were seen for both patient groups compared 
to the waiting list control group: 65% of the chronic tic disorder 
group and 74% of the TS group had reductions of more than 35% 
on the Tourette Syndrome Global Scale (TSGS). YGTSS total tic 
scores were also significantly decreased for both patient groups. At 
the end of treatment 78 of 85 completers were rated as having no 
more than mild symptoms, regardless of the starting severity, while 
the other 7 were considered to have moderate symptoms. Large 
effect sizes were seen for tic subtypes (i.e., simple, complex, motor, 
phonic) and similar results were seen across tic body locations. The 
TSGS improvements were maintained in the 52 subjects who com-
pleted a 6-month follow-up evaluation.
A study by the same group examined the effects of this psychother-
apy approach on event-related potentials and lateralized readiness 
potentials (LRPs)67. EEGs were recorded for 20 TS subjects and 20 
control subjects matched for age, sex and intelligence while per-
forming a stimulus-response compatibility inhibition task. During 
the No-Go condition, the TS group exhibited a delayed and over-
activated frontal late positive component on the No-Go portion of 
the task. The authors considered this frontal activation as evidence 
of an adaptive mechanism that allowed patients to perform simi-
larly to the control subjects on the task. This difference did not nor-
malize with psychotherapy, consistent with this interpretation. TS 
subjects exhibited a larger incorrect activation of the stimulus-
locked LRP (sLRP) in addition to larger correct activation of the 
sLRP and delayed correct activation sLRP onset. Although sLRP 
onset and response-locked LRP (rLRP) peak normalized after 
psychotherapy, the larger sLRP amplitude did not. The authors 
suggested that therapy produced some normalization of activation 
in the premotor and motor cortex.
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Medication. Efforts to maximize the value of pharmacological 
treatment continue. Lemmon et al. reported on a carefully 
designed, thoughtful pilot study of glutamatergic modulators as tic 
treatment68. Twenty-three children with TS completed a double-
blind, parallel group study involving 6 weeks of placebo, D-serine 
(up to 30 mg/kg/day) or riluzole (up to 200 mg/day). YGTSS total 
tic scores improved by 25–38% in each group, without significant 
group differences. Although power was limited by the small sample 
size, this null result argues against eager pursuit of glutamatergic 
medications for TS at this juncture.
A meta-analysis of 22 randomized, controlled trials (RCTs) involv-
ing 2,385 children with ADHD found no causal relationship 
between stimulants and onset of tics69. Rather, tics were associated 
with ADHD itself (5.7% in the psychostimulant groups and 6.5% in 
the placebo groups). This summary of previous evidence hopefully 
can further reassure patients and prescribers that stimulants do not 
cause tics. The evidence for this conclusion is strongest for methyl-
phenidate (19 of the 22 trials), and in a large RCT in children with 
TS and ADHD, tics improved significantly with methylphenidate70. 
In the meta-analysis, results were similar for the 3 trials involving 
amphetamines, but tic severity did increase in 12 adults with TS 
after a single intravenous dose of 0.3mg/kg D-amphetamine71.
Four patients with treatment-refractory TS were studied in an early 
report of results using vigabatrin, a medication from the GABA-
aminotransferase inhibitor class72. One patient had a clinically 
significant reduction in tics while two others had tic reduction of 
approximately 25% but did not report subjective clinical improve-
ment. Further study will be needed.
Neurosurgery. A revised consensus statement on the use of DBS 
in TS appeared recently73. It provides an important update to the 
2006 recommendations74, guided by almost a decade of generally 
positive results from an increasingly varied set of patients, though 
with limited evidence from randomized allocation treatment 
studies. Several major changes were made in the recommendations. 
First, the recommendation that DBS patients be 25 years or older 
has been replaced by a focus on clinical symptoms and severity. 
However, at a minimum, local ethics committee involvement was 
recommended for patients under 18 years of age. The second major 
modification in the guidelines was that a patient have a caregiver 
who would be available to accompany the patient to frequent 
follow-up appointments. In addition, the group recommended 
absence of active suicidal or homicidal ideation for 6 months 
prior to surgery. The final change in the guidelines recommended 
identifying and addressing personality disorders, malingering, 
factitious symptoms, embellishment, and other factors that can 
substantially complicate assessment and treatment.
Treatment effectiveness was examined by randomly allocated 
to DBS on-stimulation or off-stimulation conditions for the first 
3 months after DBS leads were placed in the GPi (globus pallidus, 
pars interna). Patients were then switched to the other condition 
for another 3 months75. Ratings were collected blind to stimulation 
status, and 13 patients completed assessments during both conditions. 
Total YGTSS scores were 15% lower at the end of the on-stimu-
lation period compared with the off-stimulation period (p=0.048). 
Three serious adverse events occurred: two infections in the DBS 
hardware and one episode of hypomania. Further improvements 
were seen during the long-term open label treatment period. This 
study is important as it provides evidence of efficacy of stimulation 
per se from a study with random assignment to initial condition.
A case study raised the issue of temporary DBS treatment in a 
patient with TS and ADHD treated with thalamic DBS from age 
of 17 to 2376. This case highlights the issue of DBS in minors 
discussed in the consensus statement73, but without adequate con-
trols it is impossible to know whether DBS was the cause of tic 
improvement.
Other treatment. Lisanby and colleagues reported a careful, 
randomized controlled trial of repetitive transcranial magnetic 
stimulation (rTMS) aimed at the supplementary motor area (SMA) 
in 20 adults with TS77. There were suggestions of improvement, but 
on average, patients in the sham treatment group improved almost as 
much as those in the active treatment group. However, rTMS most 
effectively stimulates superficial regions of cortex, and an Israeli 
group employed a new coil designed to provide deeper stimulation 
in an open-label study of 12 patients with treatment-refractory 
TS78. On average, the 12 patients did not improve significantly, but 
the treatment was well tolerated, and a post hoc analysis showed 
benefit in the 6 patients who also had OCD. A double blind, sham-
controlled study in TS patients with OCD will be needed to confirm 
efficacy.
Cranial electrical stimulation (CES) was used in an open label trial 
to treat 42 children with TS who were less than 12 years old79. 
Patients applied electrodes to their earlobes when they went to bed 
so that they could receive the treatment on a daily basis for 24 weeks. 
Treatment sessions lasted 60 minutes and children were allowed to 
sleep during treatment. Only one child dropped out before com-
pleting the study. The mean YGTSS score significantly decreased 
from 26 when they were initially seen to 11 after treatment comple-
tion. These results must be viewed as preliminary, since an RCT is 
required to rule out spontaneous improvement.
Another treatment undergoing initial efficacy testing is an oral 
orthotic device with which some patients have reported success. 
The rationale and design of the study, and initial safety results, were 
reported at the London meeting80, and efficacy testing continues 
(see the trial summary at ClinicalTrials.gov).
Tics, family and society
Two studies examined the association between parenting a TS 
child and parental stress. Using self-report data, Stewart and col-
leagues revealed that stress in parents of 74 children with Tourette 
syndrome was highly correlated with current ADHD symptom 
burden in the child (r = .57) and, less strongly, with the child’s OCD 
symptoms (r = .40)81. However, perhaps surprising some readers, 
parental stress was not significantly correlated with current tic 
severity (r = .18, p = .13). The correlation of parental stress with 
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ADHD and OCD symptom severity was present to a similar degree 
in 48 control children without tics. These observations reinforce the 
need for optimal clinical management of TS to include appropriate 
treatment of associated comorbidities. In another study 28 par-
ents of 21 TS children completed questionnaires on their anxiety, 
depression, and perceived stress82. Eight of the parents reported a 
moderate or severe level of anxiety. In general, parents varied in 
terms of their self-reports of their coping skills and social support 
availability. These results remind clinicians that it is important to 
evaluate the social support available to families of TS children, and 
suggest that increasing parental coping skills may improve the qual-
ity of life in TS families.
Attitudes toward treatment were investigated using a survey of 
295 parents of youth with TS and interviews with 42 young peo-
ple with TS83. These subjects were identified through Tourettes 
Action, a non-profit organization in the U.K. Patients tended to 
view aripiprazole more positively than other treatments. Three 
quarters of parents wanted access to behavior therapy for their 
child, but reported substantial trouble finding it. On the other 
hand, many young people were skeptical that behavior therapy 
would help. Importantly, patients identified several treatment out-
comes other than tics per se as important to them: reduction of 
premonitory urges, increasing control over tics, and reducing 
anxiety.
Additional reference sources
David Shprecher and colleagues recently published a thought-
ful, forward-looking, but concise review of Tourette research and 
treatment84. Mary Robertson85–88 reviews work that she and col-
leagues have done during her 35-year career treating TS patients 
and her 30 years of publishing TS research. Jankovic provided an 
overview of tic treatments89, and one of our colleagues highly rec-
ommended a review of current medication treatment practice in 
Germany90.
Jackson et al. describe how increased motor control occurs in TS 
adolescents along with a variety of compensatory mechanisms91. 
These researchers make the case that increased inhibitory capac-
ity within higher-order motor regions, such as the SMA, may alter 
motor excitability. Hawksley et al. summarize evidence suggesting 
that autonomic dysfunction may have a role in both epilepsy and 
Tourette Syndrome92. They also discuss how electrodermal activity 
biofeedback reduced seizure activity significantly in patients with 
epilepsy. In contrast, TS subjects had difficulty reducing sympa-
thetic activity, suggesting that treatment protocol modifications are 
needed for TS.
In December, 2015, a special issue on Tourette Syndrome appeared 
in the new journal Current Developmental Disorders Reports.
Four of the 5 articles are clinically focused13,93–95. The other article 
summarizes some of the recent advances in TS neuroimaging96.
Abstracts of presentations from the 1st World Congress on Tourette 
Syndrome & Tic Disorders, London, 24–26 June 2015, are available 
online. The Tourette Association at regular intervals posts links 
on its web page to selected scientific articles relevant to TS97. 
Finally, the authors are building the 2016 version of this 
article here, where readers are invited to submit suggestions or 
comments.
Conclusions
TS is a complex condition to study because of the high rate of 
comorbidities, the differences in tic severity between people iden-
tified through community studies and those who participate in 
research studies conducted at tertiary care centers, the differences 
in types of tics (e.g., vocal vs. motor tics, simple tics vs. com-
plex tics), childhood onset, and prominent fluctuations in severity 
over time. The studies published in 2015 demonstrate continued 
progress in addressing some of these obstacles.
Although many early research studies focused on the roles 
of dopamine and the basal ganglia in tic generation, more 
recent studies are adding to our understanding of the complex-
ity of tic generation and identifying possible roles for glutamate 
and histamine, along with a variety of subcortical and cortical 
regions. A number of carefully executed, large treatment studies 
have been reported, yet none is effective for more than 
about half of the patients enrolled, and side effects, cost or availability 
limit many existing treatments. Novel treatments are still 
needed.
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This was a well-written overview of research published in the TS field during 2015.  I have no major
concerns with the paper, but a couple of issues should be addressed in the paper.
The authors should make clear that this is not a methodological critique of any particular study or
set of studies. It is simply an overview.
 
The authors should take care not to insert their subjective opinions into the paper. For example, on
page 2, the authors note that "The most important genetic news of the year may have been...." I
would like the readers to make that conclusion rather than the authors.
 
The authors conclusions about the effects of why vocal tics responded so well to CBIT are
speculative (p. 8), and the authors should note that such an explanation would require
confirmation.
 
At the end of the paper, I think the authors should make calls for additional studies. The 2015 year
had things to say about why CBIT may or may not work, and the authors should call for additional
work in that area. The authors should also call for large-scale translational studies that bring
together various areas of basic science in the context of a clinical trial. This arrangement will lead
to exciting new discoveries about tics and how treatments work. Finally, the authors should
consider calling for research on optimizing treatment sequencing.
Overall, this was a useful review.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
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I read, with great interest, the manuscript by Richards and Black. Overall, it was outstanding and provides
an excellent, comprehensive review of the latest literature on Tourette Syndrome.
I recommend that it be indexed, without revisions.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
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A very comprehensive review of the TS literature in 2015 for which the authors must be thanked.
Generally speaking, they provide a brief overview of the main results / points of each paper but do not
dwell into interpretations and discussions, which is fine with me; all readers interested can look up the
primary article. Also, there are no relevant articles missing from what I can gather as I have a weekly
Pubcrawler alert for TS. The choice of papers is subjective, of course, and I was surprised not to find a
few of our own group’s contributions, listed below, but I leave it up to the authors to elaborate on them or
not.
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